These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11233295)

  • 1. [Amotivational syndrome in organic solvent abusers].
    Ozaki S; Wada K
    Nihon Yakurigaku Zasshi; 2001 Jan; 117(1):42-8. PubMed ID: 11233295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amotivational syndrome of chronic organic solvent abusers--neuropsychological study].
    Fukui K; Kobayashi T; Hayakawa S; Koga E; Ono I; Kawakami F; Fukui Y; Tani N; Kato A; Nakajima T
    Arukoru Kenkyuto Yakubutsu Ison; 1995 Oct; 30(5):367-74. PubMed ID: 8534224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case report of organic solvent abuse with amotivational syndrome].
    Kitabayashi Y; Ueda H; Matsuda M; Narumoto J; Kobayashi T; Fukui K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1999 Apr; 34(2):130-7. PubMed ID: 10355248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cerebral blood flow abnormalities in chronic solvent abusers.
    Okada S; Yamanouchi N; Kodama K; Uchida Y; Hirai S; Sakamoto T; Noda S; Komatsu N; Sato T
    Psychiatry Clin Neurosci; 1999 Jun; 53(3):351-6. PubMed ID: 10459736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of amotivational syndrome as a residual symptom after methamphetamine abuse].
    Ashizawa T; Saito T; Yamamoto M; Shichinohe S; Ishikawa H; Maeda H; Toki S; Ozawa H; Watanabe M; Takahata N
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1996 Oct; 31(5):451-61. PubMed ID: 8940805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse.
    Rovai L; Maremmani AG; Pacini M; Pani PP; Rugani F; Lamanna F; Schiavi E; Mautone S; Dell'Osso L; Maremmani I
    Riv Psichiatr; 2013; 48(1):1-9. PubMed ID: 23438696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse.
    Rosenberg NL; Grigsby J; Dreisbach J; Busenbark D; Grigsby P
    J Toxicol Clin Toxicol; 2002; 40(1):21-34. PubMed ID: 11990201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case study of BRON (cough suppressant) tablet dependence--its social psychiatric and biological aspects].
    Kitabayashi Y; Ueda H; Narumoto J; Kita H; Nakamura K; Tsuchida H; Tani N; Fukui K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2000 Oct; 35(5):295-305. PubMed ID: 11144150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Affective disorders and dementia of the frontal lobe type. Hypothesis of a pathogenic relationship].
    Luauté JP; Favel P; Rémy C; Sanabria E; Bidault E
    Encephale; 1994; 20(1):27-36. PubMed ID: 8174508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MRI findings in schizophrenic patient with frontal lobe atrophy].
    Kimura N; Inayama Y; Shigenobu K; Kakiuchi Y; Tabushi K
    Seishin Shinkeigaku Zasshi; 2004; 106(2):152-60. PubMed ID: 15052786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [So called "soft" drugs: cannabis and the amotivational syndrome].
    Schmits E; Quertemont E
    Rev Med Liege; 2013; 68(5-6):281-6. PubMed ID: 23888577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of conduct disorder related to frontal lobe syndrome in a 16-year-old girl.
    Leskauskas D; Kunca G; Adomaitienė V; Gleiznienė R; Labanauskas L
    Medicina (Kaunas); 2010; 46(12):827-34. PubMed ID: 21532287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comment on the "amotivational syndrome" in marijuana smokers.
    Kupfer DJ; Detre T; Koral J; Fajans P
    Am J Psychiatry; 1973 Dec; 130(12):1319-22. PubMed ID: 4754676
    [No Abstract]   [Full Text] [Related]  

  • 16. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests.
    Larøi F; Fannemel M; Rønneberg U; Flekkøy K; Opjordsmoen S; Dullerud R; Haakonsen M
    Psychiatry Res; 2000 Nov; 100(1):49-58. PubMed ID: 11090725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of psychiatric symptoms in a chronic solvent abuser: a case report.
    Katzelnick DJ; Davar G; Scanlon JP
    J Neuropsychiatry Clin Neurosci; 1991; 3(3):319-21. PubMed ID: 1821248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontal behavioral and emotional symptoms in Spanish individuals with acquired brain injury and substance use disorders.
    Caracuel A; Verdejo-García A; Vilar-Lopez R; Perez-Garcia M; Salinas I; Cuberos G; Coin MA; Santiago-Ramajo S; Puente AE
    Arch Clin Neuropsychol; 2008 Jul; 23(4):447-54. PubMed ID: 18450417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased frontal white-matter volume in chronic substance abuse.
    Schlaepfer TE; Lancaster E; Heidbreder R; Strain EC; Kosel M; Fisch HU; Pearlson GD
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):147-53. PubMed ID: 16004619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.